Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Breast 4Other 3Thoracic 2Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Gynecologic 2CNS 2Sarcoma 1Myeloid 1

Conditions

Myelodysplastic Syndromes 522Leukemia, Myeloid, Acute 404Leukemia, Myelogenous, Chronic, BCR-ABL Positive 308Leukemia 292Precursor Cell Lymphoblastic Leukemia-Lymphoma 234Myeloproliferative Disorders 209Lymphoma, Non-Hodgkin 167Leukemia, Myelomonocytic, Chronic 156Leukemia, Lymphocytic, Chronic, B-Cell 147Hodgkin Disease 142Primary Myelofibrosis 141Multiple Myeloma 133Leukemia, Myeloid, Chronic-Phase 133Lymphoma 114Leukemia, Myeloid, Accelerated Phase 96Blast Crisis 94Anemia, Refractory, with Excess of Blasts 89Polycythemia Vera 88Lymphoma, Follicular 84Burkitt Lymphoma 81Lymphoma, Mantle-Cell 80Myelodysplastic-Myeloproliferative Diseases 78Lymphoma, B-Cell, Marginal Zone 77Lymphoma, Large B-Cell, Diffuse 73Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 70Congenital Abnormalities 70Neoplasms, Plasma Cell 59Lymphoma, Large-Cell, Immunoblastic 59Thrombocythemia, Essential 57Graft vs Host Disease 57

Interventions

Ondansetron 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nausea × Myeloid × Clear all
NCT00954941 2015-06-25

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

M.D. Anderson Cancer Center

Phase 2 Completed
100 enrolled 7 charts
MyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Nausea, Vomiting, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡